CEO Message

Institut Pasteur Korea (IPK) is a distinguished research institute specializing in infectious diseases, established through a collaborative scientific exchange between Korea and France.

Since its founding in 2004, IPK has achieved remarkable success in both fundamental and translational research related to infectious diseases. The institute has been at the forefront of establishing and optimizing drug development platforms and infrastructure, solidifying its position as a premier hub for infectious disease Research and Development (R&D) within the Asia-Pacific region.

In response to the challenges posed by the COVID-19 public health crisis, there is worldwide recognition of the importance of infectious disease research and international cooperation. Therefore, a unified global initiative is actively underway, focusing on elevating technological competitiveness in R&D, and fostering collaborative strategies that go beyond geographical boundaries.

As a proactive participant in the global initiative, IPK is dedicated to implementing three pivotal strategies: accelerating therapeutic development, fortifying vaccine R&D, and acquiring advanced capabilities for rapid diagnostics.

First, utilizing the institute's exceptional drug discovery platform, we will not only identify new compounds targeting pathogens but also concentrate on developing drug candidates tailored for translation into clinical applications.

Second, through the enhancement of our vaccine R&D capabilities and strategic collaborations with domestic and international organizations, IPK will establish an mRNA vaccine development platform.

Third, in our commitment to ensuring a swift response to emerging infectious diseases threatening our society, we will proactively develop advanced rapid diagnostic technologies. These strategic initiatives will serve as cornerstones in our unified and comprehensive response to the challenges of infectious diseases.

Moreover, IPK is dedicated to fostering open innovation with both domestic and international partners across industry, academia, and research institutions, utilizing our robust infrastructures such as the Research Resource Center. Concurrently, collaborative initiatives with the Pasteur Network will be actively pursued to make substantial contributions to international public health.

Through these unified endeavors, IPK aims to elevate its standing to that of a world-class research institute, assuming pivotal roles in the prevention and control of infectious diseases.

Sung Key Jang

CEO of Institut Pasteur Korea